日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trial

鼻咽癌诱导化疗方案(洛铂联合氟尿嘧啶)与诱导化疗方案(顺铂联合氟尿嘧啶)后序贯同步放化疗的最终生存分析:一项多中心、随机、3期临床试验

Cao, Xun; Zhou, Jia-Yu; Huang, Hao-Yang; Guo, Ling; Huang, Ying-Ying; Qiu, Wen-Ze; Lin, Zhuo-Chen; Cao, Ka-Jia; Mo, Hao-Yuan; Li, Xian-Ming; Li, Zi-Huang; Han, Fei; He, Yu-Xiang; Liu, Yu-Meng; Bai, Yong-Rui; Wu, Shao-Xiong; Ke, Liang-Ru; Chen, Xi; Liang, Chi-Xiong; Luo, Zhuo-Ying; Xia, Yue; Deng, Ying; Miao, Jing-Jing; Xia, Wei-Xiong; Liang, Hu; Zhao, Chong; Xiang, Yan-Qun; Guo, Xiang; Lv, Xing

Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma: A Phase 3 Randomized Clinical Trial

高危N2至N3期鼻咽癌患者诱导化疗与辅助放化疗的比较:一项3期随机临床试验

Guo, Shan-Shan; Li, Xiao-Yun; Liu, Li-Ting; Jia, Guo-Dong; Liu, Sai-Lan; Sun, Xue-Song; Luo, Dong-Hua; Yang, Jin-Hao; Xie, Si-Yi; Li, Yi-Fu; Lv, Xing; Xiang, Yan-Qun; Xia, Wei-Xiong; Sun, Rui; Liu, Qing; Li, Ji-Bin; Wang, Pan; Yang, Qi; Wang, Lin; Wen, Dong-Xiang; Jin, Jing; Lin, Jie-Yi; Mo, Hao-Yuan; Guo, Ling; Zhao, Chong; Guo, Xiang; Chen, Qiu-Yan; Tang, Lin-Quan; Mai, Hai-Qiang

Chiral valley edge states based on Dirac mass engineering

基于狄拉克质量工程的手性谷边缘态

Liu, Jian-Wei; Liu, Gui-Geng; Zhang, Bo; Mo, Hao-Chang; Li, Ruifeng; Li, Mingwei; Chen, Xiao-Dong; Zhang, Baile; Chen, Wen-Jie; Dong, Jian-Wen

Epstein-Barr virus DNA-guided chemoradiotherapy for patients with low-risk locoregionally advanced nasopharyngeal carcinoma: a secondary 5-year follow-up analysis of an open-label, randomised controlled, phase 2 non-inferiority trial

Epstein-Barr病毒DNA指导的放化疗治疗低危局部晚期鼻咽癌患者:一项开放标签、随机对照、II期非劣效性试验的5年随访二次分析

Li, Yu-Chen; Li, Xiao-Yun; Lan, Kai-Qi; Cheng, Hui; Chen, Jie; Liu, Li-Ting; Wen, Dong-Xiang; Gu, Li-Wen; Guo, Wan-Ping; Sun, Xue-Song; Liu, Sai-Lan; Yang, Jin-Hao; Li, Su-Chen; Li, Yi-Fu; Long, Hao-Xiang; Luo, Dong-Hua; Guo, Ling; Mo, Hao-Yuan; Sun, Rui; Guo, Shan-Shan; Wang, Pan; Li, Li-Bin; Yang, Qi; Liang, Yu-Jing; Jia, Guo-Dong; Yan, Jin-Jie; Zhao, Chong; Chen, Qiu-Yan; Li, Liang-Ji; Mai, Hai-Qiang; Tang, Lin-Quan

Effective venetoclax treatment for indolent T-cell lymphoma of the gastrointestinal tract: a case report and literature review

维奈托克治疗胃肠道惰性T细胞淋巴瘤的有效性:病例报告及文献综述

Jian, Ji-Mo; Hao, Hong-Yuan; Yuan, Cheng-Lu; Zhang, Shu-Qi; Huang, Zou-Fang; Du, Jun

StarWhisper Telescope: an AI framework for automating end-to-end astronomical observations

StarWhisper望远镜:一个用于自动化端到端天文观测的AI框架

Wang, Cunshi; Zhang, Yu; Li, Yuyang; Hu, Xinjie; Mao, Yiming; Chen, Xunhao; Du, Pengliang; Wang, Rui; Wu, Ying; Yang, Hang; Li, Yansong; Wang, Beichuan; Mu, Haiyang; Chen, Xiaohan; He, Shunxuan; Mo, Hao; Zhang, Liyue; Du, Lin; Zhao, Yunning; Tian, Jianfeng; Ge, Liang; Mao, Yongna; Li, Shengming; Wang, Zheng; Lu, Xiaomeng; Zou, Jinhang; Huang, Yang; Sun, Ningchen; Zheng, Jie; He, Min; Bai, Yu; Jin, Junjie; Wu, Hong; Liu, Jifeng

Dysregulated Wnt/β-catenin signaling confers resistance to cuproptosis in cancer cells

失调的 Wnt/β-catenin 信号使癌细胞对杯状凋亡产生抵抗力

Yuan-Tong Liu #, Lei Chen #, Shu-Jin Li, Wu-Yin Wang, Yuan-Yuan Wang, Qi-Chao Yang, An Song, Meng-Jie Zhang, Wen-Tao Mo, Hao Li, Chuan-Yu Hu, Zhi-Jun Sun

A TGF-β signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response

一种与TGF-β信号通路相关的lncRNA特征可用于预测胶质瘤预后、免疫微环境和免疫治疗反应

Duan, Wei-Wei; Yang, Li-Ting; Liu, Jian; Dai, Zi-Yu; Wang, Ze-Yu; Zhang, Hao; Zhang, Xun; Liang, Xi-Song; Luo, Peng; Zhang, Jian; Liu, Zao-Qu; Zhang, Nan; Mo, Hao-Yang; Qu, Chun-Run; Xia, Zhi-Wei; Cheng, Quan

CRISPR-Cas9 screening develops an epigenetic and transcriptional gene signature for risk stratification and target prediction in neuroblastoma

CRISPR-Cas9 筛选开发出一种表观遗传和转录基因特征,用于神经母细胞瘤的风险分层和靶标预测

Liaoran Zhang #, Jialin Mo #, Hao Shi #, Jing Xiong, Yeerfan Aierken, Feng Chen, Yujie Tang, Kewen Zhao, Zhibao Lv, Kezhe Tan

Individualised cumulative cisplatin dose for locoregionally advanced nasopharyngeal carcinoma patients based on induction chemotherapy response and tumour volume

根据诱导化疗反应和肿瘤体积,为局部晚期鼻咽癌患者制定个体化的顺铂累积剂量方案

Lin, Jie-Yi; Lu, Zi-Jian; Li, Su-Chen; Luo, Dong-Hua; Liu, Ting; Zhang, Wan-Ru; Yang, Zhen-Chong; Mo, Hao-Yuan; Mai, Hai-Qiang; Liu, Sai-Lan